Search results
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 19 minutes agoImmunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation PR Newswire NEW YORK, April 30
